FindTrial
Sign In

HDL and inflammatory bio markers in acute coronary syndrome

HDL cholesterol along with biomarkers of inflammation in patients with acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019631
Enrollment
231
Registered
2019-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Kasturba Hospital Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age >18years Both sexes Patients with new onset ACS confirmed by clinical presentation, ECG changes and levels of biomarkers of cardiac necrosis

Exclusion criteria

Exclusion criteria: Patients with more than one coronary event Patients on immunosuppressive drugs, NSAIDS Active infection Malignancy Autoimmune disease

Design outcomes

Primary

MeasureTime frame
To study the correlation of HDL-C and inflammatory markers In patients with acute coronary syndrome. Timepoint: 09/10/18 TO 31/08/20—

Secondary

MeasureTime frame
To study the correlation of inflammatory markers with low HDL in patients with ACS. To study clinical outcome and in- hospital mortality in patients with acute coronary syndrome Timepoint: 09/10/18 TO 31/08/20—

Countries

India

Contacts

Public ContactChekuri Mounica

Kasturba Medical College

mm.prabhu@manipal.edu9652250708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026